This company has been marked as potentially delisted and may not be actively trading. Acer Therapeutics (ACER) Short Interest Ratio & Short Volume Add Compare Share Share Short Interest Stock AnalysisBuy This Stock Acer Therapeutics Short Interest DataAcer Therapeutics (ACER) has a short interest of 524,900 shares, representing 13.78% of the float (the number of shares available for trading by the public). This marks a 6.34% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 0 shares to cover all short positions.Current Short Interest524,900 sharesPrevious Short Interest493,600 sharesChange Vs. Previous Month+6.34%Dollar Volume Sold Short$441.02 thousandShort Interest Ratio0.2 Days to CoverLast Record DateOctober 31, 2023Outstanding Shares24,460,000 sharesFloat Size3,810,000 sharesShort Percent of Float13.78%Today's Trading Volume574,675 sharesAverage Trading Volume0 sharesToday's Volume Vs. Average∞ Short Selling Acer Therapeutics? Sign up to receive the latest short interest report for Acer Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartACER Short Interest Over TimeACER Days to Cover Over TimeACER Percentage of Float Shorted Over Time Acer Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2023524,900 shares $441.02 thousand +6.3%13.8%0.2 $0.84 10/15/2023493,600 shares $375.14 thousand -6.7%N/A0.2 $0.76 9/30/2023529,100 shares $431.22 thousand -41.1%N/A0.2 $0.82 9/15/2023898,100 shares $776.14 thousand +25.2%N/A0.4 $0.86 8/31/2023717,600 shares $918.53 thousand -20.7%N/A0.3 $1.28 8/15/2023905,400 shares $693.08 thousand +2.4%N/A6.1 $0.77 7/31/2023884,100 shares $769.17 thousand -2.7%N/A5.3 $0.87 7/15/2023908,200 shares $735.64 thousand +1.3%N/A5.1 $0.81 6/30/2023896,400 shares $827.74 thousand +14.7%N/A4.5 $0.92 6/15/2023781,500 shares $681.47 thousand -3.7%N/A3.6 $0.87 Get the Latest News and Ratings for ACER and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Acer Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/31/2023811,900 shares $722.59 thousand -18.4%N/A2.3 $0.89 5/15/2023994,500 shares $751.74 thousand -9.6%N/A3.2 $0.76 4/30/20231,100,000 shares $965.36 thousand -6.8%N/A3.6 $0.88 4/15/20231,180,000 shares $1.35 million -7.1%N/A3.6 $1.14 3/31/20231,270,000 shares $963.30 thousand +275.5%N/A3 $0.76 3/15/2023338,200 shares $541.12 thousand +14.4%N/A0.6 $1.60 2/28/2023295,600 shares $600.07 thousand +3.4%N/A0.5 $2.03 2/15/2023285,800 shares $597.32 thousand -42.6%N/A0.5 $2.09 1/31/2023498,300 shares $1.16 million +85.7%N/A0.8 $2.32 1/15/2023268,400 shares $805.20 thousand -36.7%2.1%0.5 $3.00 12/30/2022424,300 shares $1.06 million -35.5%3.3%0.9 $2.51 12/15/2022657,800 shares $2.12 million +932.7%5.1%1.8 $3.22 11/30/202263,700 shares $80.90 thousand +14.8%0.5%0.6 $1.27 11/15/202255,500 shares $67.16 thousand -35.5%0.4%0.8 $1.21 10/31/202286,100 shares $109.35 thousand +44.5%0.6%0.9 $1.27 10/15/202259,600 shares $72.71 thousand -23.3%0.4%0.6 $1.22 9/30/202277,700 shares $108.00 thousand -2.0%0.6%0.8 $1.39 9/15/202279,300 shares $118.16 thousand +19.3%0.6%0.7 $1.49 8/31/202266,500 shares $89.78 thousand -18.8%0.5%0.5 $1.35 8/15/202281,900 shares $124.49 thousand -49.2%2.2%0.6 $1.52 7/31/2022161,300 shares $225.06 thousand +7.0%4.2%1.1 $1.40 7/15/2022150,700 shares $231.19 thousand -7.6%4.0%1 $1.53 6/30/2022163,000 shares $205.38 thousand +49.3%4.3%0.9 $1.26 6/15/2022109,200 shares $197.65 thousand -24.6%2.9%0.2 $1.81 5/31/2022144,900 shares $346.31 thousand -41.0%1.1%0.3 $2.39 5/15/2022245,600 shares $476.46 thousand +313.5%1.9%0.5 $1.94 4/30/202259,400 shares $122.36 thousand -14.5%0.5%0.1 $2.06 4/15/202269,500 shares $159.85 thousand +58.7%0.5%0.2 $2.30 3/31/202243,800 shares $127.02 thousand -51.2%0.4%0.1 $2.90 3/15/202289,700 shares $211.69 thousand -46.9%0.7%1.6 $2.36Always trust the data (Ad)The latest statements from the President or the Federal Reserve Chairman don’t confuse it. Weiss Ratings uses the data to eliminate bias. And what human isn’t biased? It’s no different for investors. That’s why you need a sober-minded guide through market confusion.Click here to find out what Weiss Ratings says now. 2/28/2022169,000 shares $419.12 thousand +1.4%1.4%3.2 $2.48 2/15/2022166,600 shares $406.50 thousand -7.0%1.4%3.1 $2.44 1/31/2022179,100 shares $362.68 thousand -9.9%1.5%3.3 $2.03 1/15/2022198,700 shares $439.13 thousand -13.2%1.6%3.1 $2.21 12/31/2021228,900 shares $521.89 thousand -27.1%1.9%3 $2.28 12/15/2021314,000 shares $665.68 thousand +14.5%2.6%1.1 $2.12 11/30/2021274,200 shares $575.82 thousand +1.5%2.3%0.9 $2.10 11/15/2021270,100 shares $648.35 thousand -14.7%2.2%0.9 $2.40 10/29/2021316,500 shares $743.78 thousand -10.5%2.6%1.1 $2.35 10/15/2021353,700 shares $859.49 thousand +139.2%2.9%0.8 $2.43 9/30/2021147,900 shares $378.62 thousand -14.8%1.2%0.3 $2.56 9/15/2021173,600 shares $446.15 thousand -13.5%1.4%0.8 $2.57 8/31/2021200,600 shares $527.58 thousand -37.4%1.7%0.9 $2.63 8/13/2021320,400 shares $784.98 thousand +361.0%2.6%1.4 $2.45 7/30/202169,500 shares $177.92 thousand +53.4%0.6%0.3 $2.56 7/15/202145,300 shares $110.53 thousand -9.2%0.4%0.5 $2.44 6/30/202149,900 shares $142.71 thousand +4.2%0.4%0.5 $2.86 6/15/202147,900 shares $138.91 thousand -64.5%0.4%0.3 $2.90 5/28/2021135,000 shares $395.55 thousand -34.1%1.1%0.2 $2.93 5/14/2021204,700 shares $515.84 thousand -24.4%N/A0.3 $2.52 4/30/2021270,800 shares $801.57 thousand -34.4%N/A0.4 $2.96 4/15/2021412,900 shares $1.19 million +26.3%N/A0.5 $2.87 3/31/2021326,900 shares $974.16 thousand +235.6%N/A0.2 $2.98 3/15/202197,400 shares $332.13 thousand +6.1%N/A0.1 $3.41 2/26/202191,800 shares $291.01 thousand -27.2%N/A0.1 $3.17 2/12/2021126,100 shares $503.14 thousand -52.6%1.3%0.2 $3.99 1/29/2021265,900 shares $1.01 million +28.3%3.1%0.3 $3.79 1/15/2021207,300 shares $592.88 thousand -43.3%2.4%0.3 $2.86 12/31/2020365,800 shares $976.69 thousand -12.1%4.9%2.4 $2.67 12/15/2020416,100 shares $986.16 thousand -16.4%5.6%3 $2.37 11/30/2020497,600 shares $1.29 million +43.0%6.7%4.3 $2.60 11/15/2020348,000 shares $974.40 thousand -35.3%4.8%2.6 $2.80 10/30/2020538,100 shares $1.42 million -2.6%7.6%2 $2.64 10/15/2020552,300 shares $1.56 million +10.1%7.8%1.3 $2.83 9/30/2020501,500 shares $1.44 million +18.1%7.6%1.1 $2.88 9/15/2020424,800 shares $1.05 million -21.9%6.5%0.9 $2.47 8/31/2020544,100 shares $1.44 million +41.1%8.3%1.1 $2.65 8/14/2020385,700 shares $1.48 million +10.5%6.8%0.8 $3.85 7/31/2020349,000 shares $1.30 million -0.4%6.2%0.8 $3.73 7/15/2020350,300 shares $1.09 million -7.5%6.8%1.3 $3.11 6/30/2020378,800 shares $1.39 million -34.5%7.4%1.5 $3.66 6/15/2020578,500 shares $1.92 million +8.6%11.3%2.8 $3.32 ACER Short Interest - Frequently Asked Questions What is Acer Therapeutics' current short interest? Short interest is the volume of Acer Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 524,900 shares of ACER short. 13.78% of Acer Therapeutics' shares are currently sold short. Learn More on Acer Therapeutics' current short interest. What is a good short interest percentage for Acer Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.78% of Acer Therapeutics' floating shares are currently sold short. Is Acer Therapeutics' short interest increasing or decreasing? Acer Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 524,900 shares, an increase of 6.3% from the previous total of 493,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Acer Therapeutics' float size? Acer Therapeutics currently has issued a total of 24,460,000 shares. Some of Acer Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acer Therapeutics currently has a public float of 3,810,000 shares. How does Acer Therapeutics' short interest compare to its competitors? 13.78% of Acer Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Acer Therapeutics: Assertio Holdings, Inc. (6.37%), Adicet Bio, Inc. (3.56%), Seres Therapeutics, Inc. (12.41%), Forte Biosciences, Inc. (2.44%), Exicure, Inc. (1.30%), Repare Therapeutics Inc. (1.80%), Skye Bioscience, Inc. (17.97%), Werewolf Therapeutics, Inc. (6.70%), Adlai Nortye Ltd. (0.01%), Telomir Pharmaceuticals, Inc. (12.58%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: RTX Co. ($9.07 billion), T-Mobile US, Inc. ($3.71 billion), Charter Communications, Inc. ($3.51 billion), Occidental Petroleum Co. ($2.81 billion), Lululemon Athletica Inc. ($2.35 billion), Tractor Supply ($2.26 billion), Coinbase Global, Inc. ($1.88 billion), Rivian Automotive, Inc. ($1.71 billion), Celsius Holdings, Inc. ($1.67 billion), and Newmont Co. ($1.66 billion). View all of the most shorted stocks. What does it mean to sell short Acer Therapeutics stock? Short selling ACER is an investing strategy that aims to generate trading profit from Acer Therapeutics as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Acer Therapeutics? A short squeeze for Acer Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ACER, which in turn drives the price of the stock up even further. How often is Acer Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACER, twice per month. The most recent reporting period available is October, 31 2023. More Short Interest Resources from MarketBeat Related Companies ASRT Short Squeeze ACET Short Squeeze MCRB Short Squeeze FBRX Short Squeeze XCUR Short Squeeze RPTX Short Squeeze SKYE Short Squeeze HOWL Short Squeeze ANL Short Squeeze TELO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ACER) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Real Reason Silver Prices Are SoaringElon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | SponsoredThe Age of Chaos has begunThis is one of the most confusing markets in history. We have entered an Age of Chaos. And you must take...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acer Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acer Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACER Stock Free ACER Stock Alerts